Open AccessCritical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways
Author(s) -
Yaron R. Hadari,
Noriko Gotoh,
Haruhiko Kouhara,
Irit Lax,
Joseph Schlessinger
Publication year - 2001
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.161259898
Subject(s) - fibroblast growth factor receptor 2 , fibroblast growth factor , fibroblast growth factor receptor 1 , signal transduction , fibroblast growth factor receptor , microbiology and biotechnology , fibroblast growth factor receptor 3 , fibroblast growth factor receptor 4 , biology , cancer research , biochemistry , receptor
The docking protein FRS2 alpha has been implicated as a mediator of signaling via fibroblast growth factor receptors (FGFRs). We have demonstrated that targeted disruption of FRS2 alpha gene causes severe impairment in mouse development resulting in embryonal lethality at E7.0--E7.5. Experiments with FRS2 alpha-deficient fibroblasts demonstrate that FRS2 alpha plays a critical role in FGF-induced mitogen-activated protein (MAP) kinase stimulation, phosphatidylinositol-3 (PI-3) kinase activation, chemotactic response, and cell proliferation. Following FGF stimulation, tyrosine phosphorylated FRS2 alpha functions as a site for coordinated assembly of a multiprotein complex that includes Gab1 and the effector proteins that are recruited by this docking protein. Furthermore, we demonstrate that different tyrosine phosphorylation sites on FRS2 alpha are responsible for mediating different FGF-induced biological responses. These experiments establish the central role of FRS2 alpha in signaling via FGFRs and demonstrate that FRS2 alpha mediates multiple FGFR-dependent signaling pathways critical for embryonic development.